Publication | Closed Access

Difficulties in deciding whether to ablate patients with putatively “low–intermediate-risk” differentiated thyroid carcinoma: do guidelines mainly apply in the centres that produce them? Results of a retrospective, two-centre quality assurance study

Thyroid CarcinomaMedicineThyroid DiseaseThyroid HormoneOncologyRadiation OncologyCancer ResearchRadiologyHealth Sciences